Target intelligence / Profile preview

ZNF628 divergent transcript (ZNF628-DT)

Target
ZNF628-DT
Molecular classification
Long non-coding RNA (lncRNA), Divergent transcript
01

Overview

ZNF628 divergent transcript (ZNF628-DT) is a long non-coding RNA located near the ZNF628 gene on chromosome 19. Divergent transcripts, as defined by the HUGO Gene Nomenclature Committee (HGNC), are lncRNA genes found within several hundred nucleotides upstream or downstream of protein-coding genes, transcribed in the opposite orientation[5]. ZNF628-DT does not code for a protein, and there is no evidence that it is a therapeutic target, marker, or implicated in disease processes[1][2][5]. Divergent transcripts are often produced as a byproduct of active gene transcription, sometimes involved in regulatory or evolutionary processes, but specific functional roles for ZNF628-DT have not been reported[4][5]. Notes on correctness: - ZNF628-DT is not itself a protein, receptor, or enzymatic target. - The entry likely represents an annotation or transcript of unclear or uncharacterized functional relevance, rather than a molecule of direct therapeutic interest. - If a therapeutic target was intended, a confusion between ZNF628 (the protein-coding gene) and ZNF628-DT (the non-coding RNA) may have occurred[3][6]. - There are no drugs, biomarkers, or disease associations currently recognized for ZNF628-DT. If you require information on the protein-coding gene ZNF628 itself (zinc finger protein 628), that gene is a DNA-binding transcription factor, but ZNF628-DT is not the same entity[3][6].

Other names
ZNF628-DTZNF628 divergent transcript
02

Mechanism of action

Not applicable

03

Biological functions

None clearly established; no functional annotation available
04

Disease associations

None directly associated; no evidence for involvement in disease

Beyond the preview

Go deeper on ZNF628 divergent transcript (ZNF628-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZNF628 divergent transcript (ZNF628-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call